Global Mesalamine Market Insights, Forecast to 2026
SKU ID : QYR-15562061 | Publishing Date : 15-Apr-2020 | No. of pages : 119
Detailed TOC of Global Mesalamine Market Insights, Forecast to 2026
1 Study Coverage1.1 Mesalamine Product Introduction
1.2 Market Segments
1.3 Key Mesalamine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Mesalamine Market Size Growth Rate by Type
1.4.2 Purity ≥ 97 %
1.4.3 Purity ≥ 98 %
1.4.4 Purity ≥ 99 %
1.5 Market by Application
1.5.1 Global Mesalamine Market Size Growth Rate by Application
1.5.2 Mesalazine Tablets
1.5.3 Mesalazine Capsules
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Mesalamine Industry Impact
1.6.1 How the Covid-19 is Affecting the Mesalamine Industry
1.6.1.1 Mesalamine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Mesalamine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Mesalamine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Mesalamine Market Size Estimates and Forecasts
2.1.1 Global Mesalamine Revenue 2015-2026
2.1.2 Global Mesalamine Sales 2015-2026
2.2 Mesalamine Market Size by Region: 2020 Versus 2026
2.2.1 Global Mesalamine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Mesalamine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Mesalamine Competitor Landscape by Players
3.1 Mesalamine Sales by Manufacturers
3.1.1 Mesalamine Sales by Manufacturers (2015-2020)
3.1.2 Mesalamine Sales Market Share by Manufacturers (2015-2020)
3.2 Mesalamine Revenue by Manufacturers
3.2.1 Mesalamine Revenue by Manufacturers (2015-2020)
3.2.2 Mesalamine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Mesalamine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Mesalamine Revenue in 2019
3.2.5 Global Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Mesalamine Price by Manufacturers
3.4 Mesalamine Manufacturing Base Distribution, Product Types
3.4.1 Mesalamine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Mesalamine Product Type
3.4.3 Date of International Manufacturers Enter into Mesalamine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Mesalamine Market Size by Type (2015-2020)
4.1.1 Global Mesalamine Sales by Type (2015-2020)
4.1.2 Global Mesalamine Revenue by Type (2015-2020)
4.1.3 Mesalamine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Mesalamine Market Size Forecast by Type (2021-2026)
4.2.1 Global Mesalamine Sales Forecast by Type (2021-2026)
4.2.2 Global Mesalamine Revenue Forecast by Type (2021-2026)
4.2.3 Mesalamine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Mesalamine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Mesalamine Market Size by Application (2015-2020)
5.1.1 Global Mesalamine Sales by Application (2015-2020)
5.1.2 Global Mesalamine Revenue by Application (2015-2020)
5.1.3 Mesalamine Price by Application (2015-2020)
5.2 Mesalamine Market Size Forecast by Application (2021-2026)
5.2.1 Global Mesalamine Sales Forecast by Application (2021-2026)
5.2.2 Global Mesalamine Revenue Forecast by Application (2021-2026)
5.2.3 Global Mesalamine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Mesalamine by Country
6.1.1 North America Mesalamine Sales by Country
6.1.2 North America Mesalamine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Mesalamine Market Facts & Figures by Type
6.3 North America Mesalamine Market Facts & Figures by Application
7 Europe
7.1 Europe Mesalamine by Country
7.1.1 Europe Mesalamine Sales by Country
7.1.2 Europe Mesalamine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Mesalamine Market Facts & Figures by Type
7.3 Europe Mesalamine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Mesalamine by Region
8.1.1 Asia Pacific Mesalamine Sales by Region
8.1.2 Asia Pacific Mesalamine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Mesalamine Market Facts & Figures by Type
8.3 Asia Pacific Mesalamine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Mesalamine by Country
9.1.1 Latin America Mesalamine Sales by Country
9.1.2 Latin America Mesalamine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Mesalamine Market Facts & Figures by Type
9.3 Central & South America Mesalamine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Mesalamine by Country
10.1.1 Middle East and Africa Mesalamine Sales by Country
10.1.2 Middle East and Africa Mesalamine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Mesalamine Market Facts & Figures by Type
10.3 Middle East and Africa Mesalamine Market Facts & Figures by Application
11 Company Profiles
11.1 Syntese A/S
11.1.1 Syntese A/S Corporation Information
11.1.2 Syntese A/S Description, Business Overview and Total Revenue
11.1.3 Syntese A/S Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Syntese A/S Mesalamine Products Offered
11.1.5 Syntese A/S Recent Development
11.2 Divis Laboratories
11.2.1 Divis Laboratories Corporation Information
11.2.2 Divis Laboratories Description, Business Overview and Total Revenue
11.2.3 Divis Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Divis Laboratories Mesalamine Products Offered
11.2.5 Divis Laboratories Recent Development
11.3 Cambrex Corporation
11.3.1 Cambrex Corporation Corporation Information
11.3.2 Cambrex Corporation Description, Business Overview and Total Revenue
11.3.3 Cambrex Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cambrex Corporation Mesalamine Products Offered
11.3.5 Cambrex Corporation Recent Development
11.4 Ipca Laboratories
11.4.1 Ipca Laboratories Corporation Information
11.4.2 Ipca Laboratories Description, Business Overview and Total Revenue
11.4.3 Ipca Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ipca Laboratories Mesalamine Products Offered
11.4.5 Ipca Laboratories Recent Development
11.5 PharmaZell
11.5.1 PharmaZell Corporation Information
11.5.2 PharmaZell Description, Business Overview and Total Revenue
11.5.3 PharmaZell Sales, Revenue and Gross Margin (2015-2020)
11.5.4 PharmaZell Mesalamine Products Offered
11.5.5 PharmaZell Recent Development
11.6 Lasa Loboratory
11.6.1 Lasa Loboratory Corporation Information
11.6.2 Lasa Loboratory Description, Business Overview and Total Revenue
11.6.3 Lasa Loboratory Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Lasa Loboratory Mesalamine Products Offered
11.6.5 Lasa Loboratory Recent Development
11.7 Erregierre SpA
11.7.1 Erregierre SpA Corporation Information
11.7.2 Erregierre SpA Description, Business Overview and Total Revenue
11.7.3 Erregierre SpA Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Erregierre SpA Mesalamine Products Offered
11.7.5 Erregierre SpA Recent Development
11.8 Corden Pharma Bergamo
11.8.1 Corden Pharma Bergamo Corporation Information
11.8.2 Corden Pharma Bergamo Description, Business Overview and Total Revenue
11.8.3 Corden Pharma Bergamo Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Corden Pharma Bergamo Mesalamine Products Offered
11.8.5 Corden Pharma Bergamo Recent Development
11.9 CTX Lifescience
11.9.1 CTX Lifescience Corporation Information
11.9.2 CTX Lifescience Description, Business Overview and Total Revenue
11.9.3 CTX Lifescience Sales, Revenue and Gross Margin (2015-2020)
11.9.4 CTX Lifescience Mesalamine Products Offered
11.9.5 CTX Lifescience Recent Development
11.10 Ishita Active Pharma Ingredients
11.10.1 Ishita Active Pharma Ingredients Corporation Information
11.10.2 Ishita Active Pharma Ingredients Description, Business Overview and Total Revenue
11.10.3 Ishita Active Pharma Ingredients Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Ishita Active Pharma Ingredients Mesalamine Products Offered
11.10.5 Ishita Active Pharma Ingredients Recent Development
11.1 Syntese A/S
11.1.1 Syntese A/S Corporation Information
11.1.2 Syntese A/S Description, Business Overview and Total Revenue
11.1.3 Syntese A/S Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Syntese A/S Mesalamine Products Offered
11.1.5 Syntese A/S Recent Development
11.12 Xinxiang Tianfeng Fine Chemical
11.12.1 Xinxiang Tianfeng Fine Chemical Corporation Information
11.12.2 Xinxiang Tianfeng Fine Chemical Description, Business Overview and Total Revenue
11.12.3 Xinxiang Tianfeng Fine Chemical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Xinxiang Tianfeng Fine Chemical Products Offered
11.12.5 Xinxiang Tianfeng Fine Chemical Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Mesalamine Market Estimates and Projections by Region
12.1.1 Global Mesalamine Sales Forecast by Regions 2021-2026
12.1.2 Global Mesalamine Revenue Forecast by Regions 2021-2026
12.2 North America Mesalamine Market Size Forecast (2021-2026)
12.2.1 North America: Mesalamine Sales Forecast (2021-2026)
12.2.2 North America: Mesalamine Revenue Forecast (2021-2026)
12.2.3 North America: Mesalamine Market Size Forecast by Country (2021-2026)
12.3 Europe Mesalamine Market Size Forecast (2021-2026)
12.3.1 Europe: Mesalamine Sales Forecast (2021-2026)
12.3.2 Europe: Mesalamine Revenue Forecast (2021-2026)
12.3.3 Europe: Mesalamine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Mesalamine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Mesalamine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Mesalamine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Mesalamine Market Size Forecast by Region (2021-2026)
12.5 Latin America Mesalamine Market Size Forecast (2021-2026)
12.5.1 Latin America: Mesalamine Sales Forecast (2021-2026)
12.5.2 Latin America: Mesalamine Revenue Forecast (2021-2026)
12.5.3 Latin America: Mesalamine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Mesalamine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Mesalamine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Mesalamine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Mesalamine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Mesalamine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Mesalamine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Figures, Tables and Charts Available in Global Mesalamine Market Insights, Forecast to 2026
List of TablesTable 1. Mesalamine Market Segments
Table 2. Ranking of Global Top Mesalamine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Mesalamine Market Size Growth Rate by Type 2020-2026 (Ton) & (US$ Million)
Table 4. Major Manufacturers of Purity ≥ 97 %
Table 5. Major Manufacturers of Purity ≥ 98 %
Table 6. Major Manufacturers of Purity ≥ 99 %
Table 7. COVID-19 Impact Global Market: (Four Mesalamine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Mesalamine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Mesalamine Players to Combat Covid-19 Impact
Table 12. Global Mesalamine Market Size Growth Rate by Application 2020-2026 (Ton)
Table 13. Global Mesalamine Market Size by Region (Ton) & (US$ Million): 2020 VS 2026
Table 14. Global Mesalamine Sales by Regions 2015-2020 (Ton)
Table 15. Global Mesalamine Sales Market Share by Regions (2015-2020)
Table 16. Global Mesalamine Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Mesalamine Sales by Manufacturers (2015-2020) (Ton)
Table 18. Global Mesalamine Sales Share by Manufacturers (2015-2020)
Table 19. Global Mesalamine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Mesalamine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalamine as of 2019)
Table 21. Mesalamine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Mesalamine Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Mesalamine Price (2015-2020) (US$/Kg)
Table 24. Mesalamine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Mesalamine Product Type
Table 26. Date of International Manufacturers Enter into Mesalamine Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Mesalamine Sales by Type (2015-2020) (Ton)
Table 29. Global Mesalamine Sales Share by Type (2015-2020)
Table 30. Global Mesalamine Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Mesalamine Revenue Share by Type (2015-2020)
Table 32. Mesalamine Average Selling Price (ASP) by Type 2015-2020 (US$/Kg)
Table 33. Global Mesalamine Sales by Application (2015-2020) (Ton)
Table 34. Global Mesalamine Sales Share by Application (2015-2020)
Table 35. North America Mesalamine Sales by Country (2015-2020) (Ton)
Table 36. North America Mesalamine Sales Market Share by Country (2015-2020)
Table 37. North America Mesalamine Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Mesalamine Revenue Market Share by Country (2015-2020)
Table 39. North America Mesalamine Sales by Type (2015-2020) (Ton)
Table 40. North America Mesalamine Sales Market Share by Type (2015-2020)
Table 41. North America Mesalamine Sales by Application (2015-2020) (Ton)
Table 42. North America Mesalamine Sales Market Share by Application (2015-2020)
Table 43. Europe Mesalamine Sales by Country (2015-2020) (Ton)
Table 44. Europe Mesalamine Sales Market Share by Country (2015-2020)
Table 45. Europe Mesalamine Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Mesalamine Revenue Market Share by Country (2015-2020)
Table 47. Europe Mesalamine Sales by Type (2015-2020) (Ton)
Table 48. Europe Mesalamine Sales Market Share by Type (2015-2020)
Table 49. Europe Mesalamine Sales by Application (2015-2020) (Ton)
Table 50. Europe Mesalamine Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Mesalamine Sales by Region (2015-2020) (Ton)
Table 52. Asia Pacific Mesalamine Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Mesalamine Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Mesalamine Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Mesalamine Sales by Type (2015-2020) (Ton)
Table 56. Asia Pacific Mesalamine Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Mesalamine Sales by Application (2015-2020) (Ton)
Table 58. Asia Pacific Mesalamine Sales Market Share by Application (2015-2020)
Table 59. Latin America Mesalamine Sales by Country (2015-2020) (Ton)
Table 60. Latin America Mesalamine Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Mesalamine Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Mesalamine Revenue Market Share by Country (2015-2020)
Table 63. Latin America Mesalamine Sales by Type (2015-2020) (Ton)
Table 64. Latin America Mesalamine Sales Market Share by Type (2015-2020)
Table 65. Latin America Mesalamine Sales by Application (2015-2020) (Ton)
Table 66. Latin America Mesalamine Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Mesalamine Sales by Country (2015-2020) (Ton)
Table 68. Middle East and Africa Mesalamine Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Mesalamine Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Mesalamine Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Mesalamine Sales by Type (2015-2020) (Ton)
Table 72. Middle East and Africa Mesalamine Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Mesalamine Sales by Application (2015-2020) (Ton)
Table 74. Middle East and Africa Mesalamine Sales Market Share by Application (2015-2020)
Table 75. Syntese A/S Corporation Information
Table 76. Syntese A/S Description and Major Businesses
Table 77. Syntese A/S Mesalamine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 78. Syntese A/S Product
Table 79. Syntese A/S Recent Development
Table 80. Divis Laboratories Corporation Information
Table 81. Divis Laboratories Description and Major Businesses
Table 82. Divis Laboratories Mesalamine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 83. Divis Laboratories Product
Table 84. Divis Laboratories Recent Development
Table 85. Cambrex Corporation Corporation Information
Table 86. Cambrex Corporation Description and Major Businesses
Table 87. Cambrex Corporation Mesalamine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 88. Cambrex Corporation Product
Table 89. Cambrex Corporation Recent Development
Table 90. Ipca Laboratories Corporation Information
Table 91. Ipca Laboratories Description and Major Businesses
Table 92. Ipca Laboratories Mesalamine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 93. Ipca Laboratories Product
Table 94. Ipca Laboratories Recent Development
Table 95. PharmaZell Corporation Information
Table 96. PharmaZell Description and Major Businesses
Table 97. PharmaZell Mesalamine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 98. PharmaZell Product
Table 99. PharmaZell Recent Development
Table 100. Lasa Loboratory Corporation Information
Table 101. Lasa Loboratory Description and Major Businesses
Table 102. Lasa Loboratory Mesalamine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 103. Lasa Loboratory Product
Table 104. Lasa Loboratory Recent Development
Table 105. Erregierre SpA Corporation Information
Table 106. Erregierre SpA Description and Major Businesses
Table 107. Erregierre SpA Mesalamine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 108. Erregierre SpA Product
Table 109. Erregierre SpA Recent Development
Table 110. Corden Pharma Bergamo Corporation Information
Table 111. Corden Pharma Bergamo Description and Major Businesses
Table 112. Corden Pharma Bergamo Mesalamine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 113. Corden Pharma Bergamo Product
Table 114. Corden Pharma Bergamo Recent Development
Table 115. CTX Lifescience Corporation Information
Table 116. CTX Lifescience Description and Major Businesses
Table 117. CTX Lifescience Mesalamine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 118. CTX Lifescience Product
Table 119. CTX Lifescience Recent Development
Table 120. Ishita Active Pharma Ingredients Corporation Information
Table 121. Ishita Active Pharma Ingredients Description and Major Businesses
Table 122. Ishita Active Pharma Ingredients Mesalamine Production (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 123. Ishita Active Pharma Ingredients Product
Table 124. Ishita Active Pharma Ingredients Recent Development
Table 125. YC Biotech (Jiangsu) Corporation Information
Table 126. YC Biotech (Jiangsu) Description and Major Businesses
Table 127. YC Biotech (Jiangsu) Mesalamine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 128. YC Biotech (Jiangsu) Product
Table 129. YC Biotech (Jiangsu) Recent Development
Table 130. Xinxiang Tianfeng Fine Chemical Corporation Information
Table 131. Xinxiang Tianfeng Fine Chemical Description and Major Businesses
Table 132. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 133. Xinxiang Tianfeng Fine Chemical Product
Table 134. Xinxiang Tianfeng Fine Chemical Recent Development
Table 135. Global Mesalamine Sales Forecast by Regions (2021-2026) (Ton)
Table 136. Global Mesalamine Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Mesalamine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Mesalamine Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Mesalamine Sales Forecast by Country (2021-2026) (Ton)
Table 140. North America: Mesalamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Mesalamine Sales Forecast by Country (2021-2026) (Ton)
Table 142. Europe: Mesalamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Mesalamine Sales Forecast by Region (2021-2026) (Ton)
Table 144. Asia Pacific: Mesalamine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Mesalamine Sales Forecast by Country (2021-2026) (Ton)
Table 146. Latin America: Mesalamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Mesalamine Sales Forecast by Country (2021-2026) (Ton)
Table 148. Middle East and Africa: Mesalamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Mesalamine Players
Table 153. Mesalamine Customers List
Table 154. Mesalamine Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Mesalamine Product Picture
Figure 2. Global Mesalamine Sales Market Share by Type in 2020 & 2026
Figure 3. Purity ≥ 97 % Product Picture
Figure 4. Purity ≥ 98 % Product Picture
Figure 5. Purity ≥ 99 % Product Picture
Figure 6. Global Mesalamine Sales Market Share by Application in 2020 & 2026
Figure 7. Mesalazine Tablets
Figure 8. Mesalazine Capsules
Figure 9. Others
Figure 10. Mesalamine Report Years Considered
Figure 11. Global Mesalamine Market Size 2015-2026 (US$ Million)
Figure 12. Global Mesalamine Sales 2015-2026 (Ton)
Figure 13. Global Mesalamine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Mesalamine Sales Market Share by Region (2015-2020)
Figure 15. Global Mesalamine Sales Market Share by Region in 2019
Figure 16. Global Mesalamine Revenue Market Share by Region (2015-2020)
Figure 17. Global Mesalamine Revenue Market Share by Region in 2019
Figure 18. Global Mesalamine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Mesalamine Revenue in 2019
Figure 20. Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Mesalamine Sales Market Share by Type (2015-2020)
Figure 22. Global Mesalamine Sales Market Share by Type in 2019
Figure 23. Global Mesalamine Revenue Market Share by Type (2015-2020)
Figure 24. Global Mesalamine Revenue Market Share by Type in 2019
Figure 25. Global Mesalamine Market Share by Price Range (2015-2020)
Figure 26. Global Mesalamine Sales Market Share by Application (2015-2020)
Figure 27. Global Mesalamine Sales Market Share by Application in 2019
Figure 28. Global Mesalamine Revenue Market Share by Application (2015-2020)
Figure 29. Global Mesalamine Revenue Market Share by Application in 2019
Figure 30. North America Mesalamine Sales Growth Rate 2015-2020 (Ton)
Figure 31. North America Mesalamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Mesalamine Sales Market Share by Country in 2019
Figure 33. North America Mesalamine Revenue Market Share by Country in 2019
Figure 34. U.S. Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 35. U.S. Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 37. Canada Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Mesalamine Market Share by Type in 2019
Figure 39. North America Mesalamine Market Share by Application in 2019
Figure 40. Europe Mesalamine Sales Growth Rate 2015-2020 (Ton)
Figure 41. Europe Mesalamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Mesalamine Sales Market Share by Country in 2019
Figure 43. Europe Mesalamine Revenue Market Share by Country in 2019
Figure 44. Germany Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 45. Germany Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 47. France Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 49. U.K. Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 51. Italy Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 53. Russia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Mesalamine Market Share by Type in 2019
Figure 55. Europe Mesalamine Market Share by Application in 2019
Figure 56. Asia Pacific Mesalamine Sales Growth Rate 2015-2020 (Ton)
Figure 57. Asia Pacific Mesalamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Mesalamine Sales Market Share by Region in 2019
Figure 59. Asia Pacific Mesalamine Revenue Market Share by Region in 2019
Figure 60. China Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 61. China Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 63. Japan Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 65. South Korea Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 67. India Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 69. Australia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 71. Taiwan Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 73. Indonesia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 75. Thailand Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 77. Malaysia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 79. Philippines Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 81. Vietnam Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Mesalamine Market Share by Type in 2019
Figure 83. Asia Pacific Mesalamine Market Share by Application in 2019
Figure 84. Latin America Mesalamine Sales Growth Rate 2015-2020 (Ton)
Figure 85. Latin America Mesalamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Mesalamine Sales Market Share by Country in 2019
Figure 87. Latin America Mesalamine Revenue Market Share by Country in 2019
Figure 88. Mexico Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 89. Mexico Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 91. Brazil Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 93. Argentina Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Mesalamine Market Share by Type in 2019
Figure 95. Latin America Mesalamine Market Share by Application in 2019
Figure 96. Middle East and Africa Mesalamine Sales Growth Rate 2015-2020 (Ton)
Figure 97. Middle East and Africa Mesalamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Mesalamine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Mesalamine Revenue Market Share by Country in 2019
Figure 100. Turkey Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 101. Turkey Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 103. Saudi Arabia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. UAE Mesalamine Sales Growth Rate (2015-2020) (Ton)
Figure 105. UAE Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Mesalamine Market Share by Type in 2019
Figure 107. Middle East and Africa Mesalamine Market Share by Application in 2019
Figure 108. Syntese A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Divis Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Cambrex Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Ipca Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. PharmaZell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Lasa Loboratory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Erregierre SpA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Corden Pharma Bergamo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. CTX Lifescience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Ishita Active Pharma Ingredients Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. YC Biotech (Jiangsu) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Xinxiang Tianfeng Fine Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. North America Mesalamine Sales Growth Rate Forecast (2021-2026) (Ton)
Figure 121. North America Mesalamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Europe Mesalamine Sales Growth Rate Forecast (2021-2026) (Ton)
Figure 123. Europe Mesalamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Asia Pacific Mesalamine Sales Growth Rate Forecast (2021-2026) (Ton)
Figure 125. Asia Pacific Mesalamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Latin America Mesalamine Sales Growth Rate Forecast (2021-2026) (Ton)
Figure 127. Latin America Mesalamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Middle East and Africa Mesalamine Sales Growth Rate Forecast (2021-2026) (Ton)
Figure 129. Middle East and Africa Mesalamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Porter's Five Forces Analysis
Figure 131. Channels of Distribution
Figure 132. Distributors Profiles
Figure 133. Bottom-up and Top-down Approaches for This Report
Figure 134. Data Triangulation
Figure 135. Key Executives Interviewed
Keyplayers in Global Mesalamine Market Insights, Forecast to 2026
Syntese A/SDivis Laboratories
Cambrex Corporation
Ipca Laboratories
PharmaZell
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical